Medium materiality6/10
Ovid Therapeutics price target raised to $8 from $7 at Roth Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Roth Capital raises OVID target to $8 from $7; current price $2.80; upside implied.
- Roth Capital raises OVID target to $8; price $2.80.
Key facts
- 01
Target: $8
- 02
Posted price: $2.8
- 03
Analyst firm: Roth Capital
- 04
Analyst: Boobalan Pachaiyappan
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.